We already have some amazing speakers: serial CEO and industry conscience Tony Coles; author and reformer Atul Gawande; vaccine pioneer Barney Graham; and Yvonne Greenstreet, CEO of Alnylam, whose stock is soaring thanks to new data. But that's just the beginning.
Among the topics grabbing our attention:
The election. We'll be less than a month away from election day, and we'll be ready with perspectives on what is about to come.
The future of drug R&D. Inventing drugs is tough. We'll convene some of the top R&D names in pharma to discuss why.
Medicare's messes. We'll look at issues including questions around Medicare Advantage, in which private sector insurance companies are subcontracted to manage some patients' care, as well as other issues with the big government program.
Regulating AI. We're eager to figure out how these new innovations will be regulated – and by whom.
David vs. Goliath. We're looking at cases across health tech and biotech where a small firm confronted an incumbent – and looking for lessons learned.
Live demos. At our San Francisco Summit, a demonstration of live note-taking software was one of the key moments. We promise to show you more great tech, live on-stage.
I hope this gives you a sense of what we're planning and makes you want to be in the room as part of our audience. We'll rely on you to ask the smartest questions and deliver live feedback to the speakers.
We'd love to see you in there.
Matthew Herper X: @matthewherper Editorial Director, Events
Early Access Pricing Ends Soon!
Interested in attending this year's event? Register by Monday, July 22 to save up to $600 on your 2024 STAT Summit Passes.
No comments